NTRK1 and neoplasm: To investigate the mechanism underlying the enhanced anti-tumor activity induced by the metformin-alpelisib combination, we analyzed key markers of the receptor tyrosine kinase (RTK) pathway and related oncogenic signals, followed by examination of stemness-related pathways.